On this page
What this guide covers
Year one is the honeymoon. Year two is the hard questions: plateaus, dose changes, maintenance, and coming off. A calm, cited companion for the long haul on a GLP-1. This is patient education, not a substitute for the prescriber who knows your case. Generic names sit next to brand names throughout: semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound).
Key points
- What the long-term picture actually looks like. Most of the calm, careful content about GLP-1s is about starting. Far less is written about the part that comes after the first year, and that is exactly where the hard questions live: progress slowing down, what a higher or lower dose is for, how long to stay on it, and what happens if you come off. This guide is the map for that stretch. The honest throughline is that these are not failures or finish lines; they are predictable chapters of using a long-term medication, and they are far easier to handle when you know they are coming.
- Plateaus: usually normal, rarely a verdict. Progress slowing or stopping for a while is one of the most common and most distressing parts of the long-term experience, and it is usually a normal physiological adjustment rather than a sign the medication has quit working. The body adapts as weight comes off, and the same dose does less than it once did. Sometimes the answer is time, sometimes a dose review with your prescriber, and sometimes a look at protein, sleep, and training. Our guide on GLP-1 plateaus and not losing weight walks through what is normal, what is worth checking, and when to raise it clinically.
- Dose changes: up to keep going, down to hold. Dose is the lever people reach for first, and it cuts both ways. Moving up the titration ladder is how prescribers respond when a plateau looks like the dose has been outgrown, within the limits of each drug's label. Moving down, or holding at a lower dose, is how some people maintain once they reach a weight they want to keep. Neither is a do-it-yourself decision: the FDA labels set the dose ceilings and the titration steps, and how to use them for your situation is a prescriber call. The point is that dose is a tool with a purpose, not a score.
- How long to stay on it, and the 'forever drug' worry. One of the most-asked long-term questions is how long this lasts, and the honest answer is that obesity and type 2 diabetes are treated as chronic conditions, so these medications are generally framed as long-term rather than a short course. That unsettles a lot of people. It helps to reframe it the way clinicians do: a treatment you stay on for as long as it is helping and tolerated, reviewed regularly, the same way other long-term medications are. Our guide on how long to stay on a GLP-1 lays out what the evidence and the labels actually say, without pretending there is one tidy number.
- Coming off, and weight regain. If you stop, appetite tends to return as the drug clears, and a share of what the medication helped with often comes back, because the underlying biology of appetite has not changed. The STEP-1 extension study is the most-cited source on this pattern. This is not weak willpower; it is the predictable result of removing an appetite-regulating medication, and knowing it in advance is what makes the difference between feeling blindsided and feeling prepared. Our guide on stopping a GLP-1, written in full as Ozempic absetzen, covers how the drug clears, tapering versus stopping, and the medical reasons a prescriber may want you to pause.
Frequently asked questions
Why has my GLP-1 weight loss plateaued?
Plateaus are common and usually a normal physiological adjustment rather than the medication failing. As the body loses weight it adapts, and the same dose does less than it once did. Sometimes the answer is time, sometimes a dose review with your prescriber, and sometimes a look at protein, sleep, and resistance training. A stall that lasts a long while, or comes with other symptoms, is worth raising clinically rather than assuming the drug has stopped working.
How long can you stay on a GLP-1?
Obesity and type 2 diabetes are treated as chronic conditions, so GLP-1 medications are generally framed as long-term treatments rather than a short course, used for as long as they are helping and tolerated and reviewed regularly. There is no single fixed number, and the right duration is a decision to make with your prescriber based on your health, your response, and your situation.
What is a maintenance dose on a GLP-1?
A maintenance dose is a steady dose used to hold a result rather than to keep losing, and for some people that means staying at a lower dose once they reach a weight they want to keep. Whether and how to do this is a prescriber decision, made within each drug's labeled dose range. It is not a do-it-yourself adjustment, because dose changes affect both appetite and, in diabetes, blood sugar.
Do you regain weight after stopping a GLP-1?
Often, yes, at least in part. When the medication clears, appetite returns and a share of what it helped with tends to come back, because the underlying appetite biology has not changed; the STEP-1 extension study is the most-cited source on this. Regain is common and is not a sign of weak willpower. Steady protein, resistance training, regular meals, and sleep are the ordinary levers that soften it.
Sources
Related reading
Ozempic absetzen: was Sie vorher wissen sollten
Semaglutid (Ozempic, Wegovy) absetzen ist eine Entscheidung, die zu Ihrer Ärztin oder Ihrem Arzt gehört. Hier erfahren Sie, was die Fachinformation und die Studien zum Stoppen zeigen, warum der Appetit oft zurückkehrt und welche Gewohnheiten den Übergang tragen.
Ozempic Plateau: Why Progress Stalls
A plateau on Ozempic or another GLP-1 is common, usually normal, and rarely a sign the drug has stopped working. Here is why progress stalls and what is actually worth checking.
How Long Should You Stay on Ozempic?
There is no single tidy number for how long to stay on Ozempic or another GLP-1. Here is what the labels and the evidence actually say, and how to think about it with your prescriber.